ID   JEG-3/VP16
AC   CVCL_6922
SY   jeg3/vp16
DR   Wikidata; Q54898566
RX   PubMed=17884151;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI:4911; Etoposide (VP-16).
CC   Miscellaneous: Formerly the CCRID database had an entry describing this cell line (3111C0001CCC000072). It was the sole source for the STR profile of this entry.
CC   Derived from site: Metastatic; Fetal brain; UBERON=UBERON_0006237.
ST   Source(s): CCRID
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 9,11
ST   D16S539: 13,14
ST   D18S51: 14
ST   D19S433: 13,15
ST   D21S11: 30
ST   D2S1338: 24
ST   D3S1358: 15,16
ST   D5S818: 10,11
ST   D7S820: 10,12
ST   D8S1179: 12
ST   FGA: 21,23,24
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C4646; Gestational choriocarcinoma
DI   ORDO; Orphanet_99926; Gestational choriocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0363 ! JEG-3
SX   Male
AG   Fetus
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 17
//
RX   PubMed=17884151; DOI=10.1016/j.ygyno.2007.08.007;
RA   Chen Y., Qian H.-L., Wang H.-J., Zhang X.-Y., Fu M., Liang X., Ma Y.,
RA   Zhan Q.-M., Lin C., Xiang Y.;
RT   "Ad-PUMA sensitizes drug-resistant choriocarcinoma cells to
RT   chemotherapeutic agents.";
RL   Gynecol. Oncol. 107:505-512(2007).
//